Zydus Lifesciences Ltd share price logo

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

BSE: 532321

Mid Cap

Healthcare Sector

₹939.10

+3.05

(+0.33%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Regulatory Approval Alert

Zydus Lifesciences receives USFDA Establishment Inspection Report and approval for oncology injectable manufacturing facility in Ahmedabad.

Zydus Lifesciences Stock Performance

as on April 16, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹930.20
    ₹948.00
    downward going graph

    0.95%

    Downside

    0.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹813.00
    ₹1,059.05
    downward going graph

    13.43%

    Downside

    12.77%

    Upside

    downward going graph

Zydus Lifesciences share price movements today

Previous Close
₹936.05
Open
₹939.00
Volume
5.81L
Upper Circuit
₹1,029.65
Lower Circuit
₹842.45
Day's Low - High
₹930.20 - ₹948.00
52 Week Low - High
₹813.00 - ₹1,059.05

Zydus Lifesciences Historical Returns

1 Month Return
+ 5.54 %
3 Month Return
+ 7.83 %
1 Year Return
+ 13.86 %
3 Year Return
+ 86.43 %
5 Year Return
+ 77.58 %

Zydus Lifesciences Fundamentals

as on April 16, 2026 at 4:01 pm IST

Market Cap

₹94,188.53 Cr

Return on Equity (ROE)

31.29

PE Ratio (TTM)

19.07

Return on capital employed (ROCE)

30.47

Industry PE ratio

41.33

Beta (LTM)

0.72

P/B Ratio

4.2

Dividend Yield

1.24

PEG Ratio

4.7

Quarterly Earnings Growth YOY

-3.9

EPS (TTM)

45.87

Sector

Pharmaceuticals

Book Value

238.1

Technical Analysis

Bullish

View Technical Analysis

Zydus Lifesciences Stock Valuation

as on April 16, 2026 at 4:01 pm IST

Zydus Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (7.34x)

March 7, 2022

Today (19.07x)

April 15, 2026

Industry (41.33x)

April 15, 2026

Highest (34.62x)

March 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 19.07x

Zydus Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD94,188.5315.52%0.614,61423,241
Sanofi India Ltd image
Sanofi India Ltd
BUY8,106.33-11.25%0.004132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY79,796.338.83%0.603,48331,723
Abbott India Ltd image
Abbott India Ltd
BUY55,196.8814.71%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY40,745.5412.72%0.569273,749
See all

Market expectation of Zydus Lifesciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

35.71%

Buy

39.29%

Hold

25.00%

Sell

Zydus Lifesciences Stock’s Investor Sentiment and Interest

Investment in Zydus Lifesciences Ltd Shares on INDmoney has grown by 29.10% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:29.10% versus previous 30 day period

Search interest for Zydus Lifesciences Ltd Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Zydus Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
5,052.8
4,258.6
4,343.7
5,366.4
6,046.5
5,113.6
5,123.5
6,290.2
6,467
6,037.9
6,780.4
Other Income
36
54
59.5
159.6
63.2
68.5
57.5
80.6
154.9
109
111.4
Total Income
5,175.6
4,422.8
4,564.7
5,693.4
6,270.7
5,305.5
5,326.6
6,608.5
6,728.6
6,232.2
6,975.9
Expenses
3,649.5
3,223.7
3,402.8
3,903.3
4,123.5
3,775.6
3,881.8
4,622
4,485.2
4,141.6
5,133
Operating Profit
1,403.3
1,034.9
940.9
1,463.1
1,923
1,338
1,241.7
1,668.2
1,981.8
1,896.3
1,647.4
Operating Profit Margin %
27.77%
24.3%
21.66%
27.26%
31.8%
26.17%
24.24%
26.52%
30.64%
31.41%
24.3%
Profit Before Interest, Tax and Depreciation
1,526.1
1,199.1
1,161.9
1,790.1
2,147.2
1,529.9
1,444.8
1,986.5
2,243.4
2,090.6
1,842.9
Interest
18.1
8.7
19.8
34.6
32.2
25.1
32
76.6
84.7
101.3
129.9
Depreciation
179.8
184.2
194.8
205.3
215.3
233.6
229
237.9
238.1
301.9
359.6
Profit Before Tax
1,328.2
1,006.2
947.3
1,550.2
1,899.7
1,271.2
1,183.8
1,672
1,920.6
1,687.4
1,353.4
Tax Paid
216.1
226.4
213.8
321.2
436.1
373.1
179.5
423.2
434
454
388.3
Profit After Tax
1,112.1
779.8
733.5
1,229
1,463.6
898.1
1,004.3
1,248.8
1,486.6
1,233.4
965.1
Total Net profit including share of profit / Loss from associate company
1,133.6
803.2
789.9
1,246.1
1,482.5
920.2
1,026.2
1,243.7
1,521
1,238.6
1,022.9
EPS
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
Actual EPS
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
Adjusted EPS
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36
Diluted EPS
10.74
7.91
7.8
11.69
14.11
9.06
10.17
11.64
14.58
12.51
10.36

Zydus Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
11,581.3
12,748.4
13,812.1
14,125
14,827.6
16,877.8
19,021.5
22,573.8
Other Income
113.2
201.1
113.9
45.6
2,583.1
186.6
307.1
269.5
Total Income
12,018.1
13,366.7
14,367
14,449.1
17,693
17,424
19,854.5
23,511
Expenses
9,076.2
10,192.5
11,833.3
11,289.5
11,769.2
13,986.3
14,177.3
16,402.6
Operating Profit
2,505.1
2,555.9
1,978.8
2,835.5
3,058.4
2,891.5
4,844.2
6,171.2
Operating Profit Margin %
21.63%
20.05%
14.33%
20.07%
20.63%
17.13%
25.47%
27.34%
Profit Before Interest, Tax and Depreciation
2,941.9
3,174.2
2,533.7
3,159.6
5,923.8
3,437.7
5,677.2
7,108.4
Interest
91.1
193.5
341.8
158.8
127
129.9
81.2
165.9
Depreciation
538.8
598.6
696.5
669.6
713
722.7
764.1
915.8
Profit Before Tax
2,312
2,382.1
1,495.4
2,331.2
5,083.8
2,585.1
4,831.9
6,026.7
Tax Paid
564.4
530.3
319.8
193.6
511.7
587.8
977.5
1,411.9
Profit After Tax
1,747.6
1,851.8
1,175.6
2,137.6
4,572.1
1,997.3
3,854.4
4,614.8
Total Net profit including share of profit / Loss from associate company
1,810.4
1,898.7
1,204.4
2,185
4,618.3
2,091.9
3,972.8
4,672.6
EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Actual EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Adjusted EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97
Diluted EPS
17.35
18.06
11.49
20.85
43.84
19.3
38.14
44.97

Zydus Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,893.5
1,311.7
919.3
1,281.9
2,505.4
3,293
2,104.1
2,688.8
3,227.9
6,776.7
Cash Flow from Investing Activities
-859.6
-2,871.9
-973.7
-3,977.4
-1,012.3
-834.6
1,137.1
1,177.8
-1,492.3
-8,377.1
Cash Flow from Financing Activities
-934.8
2,315.8
51.5
1,884.6
-1,094.2
-2,548.9
-868.3
-4,400.4
-1,810.4
2,014.2
Net Cash Flow
99.1
755.6
-2.9
-810.9
398.9
-90.5
2,372.9
-533.8
-74.8
413.8

Zydus Lifesciences Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.98%
74.99%
74.99%
74.99%
75%
75%
DII
13.23%
13.09%
12.79%
12.63%
12.64%
10.65%
10.65%
11.01%
11.13%
10.86%
11.09%
11.2%
FII
0%
0%
0%
5.72%
5.59%
7.52%
7.53%
7.32%
7.13%
7.34%
7.06%
6.95%
Public
7.47%
7.07%
6.99%
6.66%
6.8%
6.85%
6.84%
6.68%
6.74%
6.8%
6.85%
6.86%
Total Outstanding Shares
1,01,22,04,139
1,01,22,04,139
1,01,22,04,139
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
1,00,62,33,990
Total Shareholders
3,11,764
2,97,953
3,06,495
2,94,324
3,36,309
3,70,863
3,65,356
3,71,619
3,86,127
3,96,105
4,03,266
4,18,314

Mutual Funds that own Zydus Lifesciences Stock

Check out the Mutual Funds with significant holdings in Zydus Lifesciences.

Zydus Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of Zydus Lifesciences.

  • Zydus Lifesciences Ltd Earnings Results

    Zydus Lifesciences Ltd’s net profit jumped 1.82% since last year same period to ₹1,042.10Cr in the Q3 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated -17.2% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Zydus Lifesciences Ltd Dividends May,2025

    In the quarter ending March 2025, Zydus Lifesciences Ltd has declared dividend of ₹11.00 per share on 19 May 2025 - translating a dividend yield of 1.18%.

    Read More about Dividends

Zydus Lifesciences News & Key Events

  • img

    Today's Timeline - 16 April

    12:49 PM

    -

    Zydus Lifesciences receives USFDA EIR for oncology injectable facility in Ahmedabad after successful inspection from November 4 to 13, 2025.

Indices Featuring Zydus Lifesciences Stock

Check stock indices that include Zydus Lifesciences.

BSE Healthcare

₹43,245.60

0.03 (▲11.53%)

Nifty100 Eq Weig

₹33,426.00

0.59 (▲194.85%)

Nifty LargeMidcap 250

₹16,146.05

0.35 (▲57.00%)

Nifty Healthcare

₹14,434.95

0.08 (▲11.30%)

Nifty Next 50

₹69,300.60

1.07 (▲731.25%)

S&P BSE 400 MidSmallCap

₹11,764.64

0.67 (▲78.84%)

Nifty 200

₹13,742.25

0.18 (▲24.60%)

S&P BSE 250 LargeMidCap

₹10,582.44

0.18 (▲19.02%)

BSE 500

₹35,485.91

0.26 (▲91.04%)

S&P BSE 150 MidCap

₹15,930.39

0.52 (▲82.94%)

BSE 200

₹11,143.03

0.15 (▲17.05%)

NIFTY 100

₹25,042.30

0.07 (▲18.60%)

S&P BSE Dividend Stability

₹1,049.35

0.35 (▲3.63%)

NIFTY PHARMA

₹22,465.00

0.13 (▲29.35%)

Nifty 500

₹22,656.30

0.27 (▲60.75%)

Nifty100 Quality

₹5,511.60

0.56 (▲30.70%)

Insights on Zydus Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.85% to 6.86% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ZYDUSLIFE stock has moved up by 7.8%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.71% to 4.88% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 6.23K Cr → 6.97K Cr (in ₹), with an average increase of 10.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 255.4% return, outperforming this stock by 168.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 75.00% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 29.1% return, outperforming this stock by 15.2%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 7.06% to 6.95% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 1.46K Cr → 1.04K Cr (in ₹), with an average decrease of 15.7% per quarter

Zydus Lifesciences Stock Futures & Options Contracts

View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.

Zydus Lifesciences Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 28 Apr ₹950 Call
April 28, 2026
₹950
₹11.45
-0.8
-6.53%
ZYDUSLIFE 28 Apr ₹940 Call
April 28, 2026
₹940
₹16.05
-0.9
-5.31%
ZYDUSLIFE 28 Apr ₹960 Call
April 28, 2026
₹960
₹7.9
-0.95
-10.73%
ZYDUSLIFE 28 Apr ₹1000 Call
April 28, 2026
₹1000
₹1.25
-0.55
-30.56%

Zydus Lifesciences Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ZYDUSLIFE 28 Apr Fut
April 28, 2026
-
₹938
-0.19
-0.02%
ZYDUSLIFE 26 May Fut
May 26, 2026
-
₹943.5
0.47
0.05%
ZYDUSLIFE 30 Jun Fut
June 30, 2026
-
₹950
1.04
0.11%

About Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is a leading pharmaceutical company headquartered in Ahmedabad, India. Incorporated in 1995, the company operates in a number of lines of business, including active pharmaceutical ingredients, formulations, biotechnology, and nutraceuticals.

The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.

Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.

Revenue: ₹6,780.40Cr as on December 2025 (Q3 FY26)
Net Profit: ₹965.10Cr as on December 2025 (Q3 FY26)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
OrganisationZydus Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOPankaj R Patel
E-voting on sharesClick here to vote

FAQs

What is Zydus Lifesciences share price today?

Zydus Lifesciences share price today stands at ₹939.1 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹948 and a low of ₹930.2.

What is the 52 week high and 52 week low range for Zydus Lifesciences share?

Zydus Lifesciences touched a 52 week high of ₹1059.05 and a 52 week low of ₹813. Zydus Lifesciences share price today i.e. is closed at ₹939.1, which is -11.33% down from its 52 week high and 15.51% up from its 52 week low.

What is Zydus Lifesciences's market capitalisation today?

Zydus Lifesciences market capitalisation is ₹94,188.53 Cr as on .

How to buy Zydus Lifesciences shares?

To buy Zydus Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Zydus Lifesciences trading volume today?

Zydus Lifesciences trading volume is 5.81L as on . This means that 5.81L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.